Prestige Consumer Healthcare Inc. beat EPS estimates 75% of the time across 16 reported quarters (12 beats, 4 misses), averaging +1.1% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q1 FY27 | $0.89 | $0.98 | +10.1% | Beat | Q1 FY27 call |
| Q4 FY26 | $1.39 | $1.23 | -11.5% | Miss | Q4 FY26 call |
| Q3 FY26 | $1.16 | $1.14 | -1.7% | Miss | Q3 FY26 call |
| Q2 FY26 | $0.97 | $1.07 | +10.3% | Beat | |
| Q1 FY26 | $1.01 | $0.95 | -5.9% | Miss | |
| Q4 FY25 | $1.30 | $1.32 | +1.5% | Beat | |
| Q3 FY25 | $1.16 | $1.22 | +5.2% | Beat | |
| Q2 FY25 | $1.09 | $1.09 | +0.0% | Beat | |
| Q1 FY25 | $0.86 | $0.90 | +4.7% | Beat | |
| Q4 FY24 | $1.14 | $1.02 | -10.5% | Miss | |
| Q3 FY24 | $1.04 | $1.06 | +1.9% | Beat | |
| Q2 FY24 | $1.07 | $1.07 | +0.0% | Beat |
Back to PBH overview · PBH holders · PBH KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.